Anti-CD19 CAR NK Cell Therapy for R/R Non-Hodgkin Lymphoma.

NCT04639739 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
9
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Xinqiao Hospital of Chongqing

Collaborators